X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Orchid Chemicals with Pfizer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs PFIZER - Comparison Results

ORCHID PHARMA LTD    Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA LTD PFIZER ORCHID PHARMA LTD/
PFIZER
 
P/E (TTM) x 0.1 30.4 0.4% View Chart
P/BV x 0.2 5.2 3.1% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 ORCHID PHARMA LTD   PFIZER
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
PFIZER
Mar-16
ORCHID PHARMA LTD/
PFIZER
5-Yr Chart
Click to enlarge
High Rs1942,724 7.1%   
Low Rs351,611 2.2%   
Sales per share (Unadj.) Rs276.5440.9 62.7%  
Earnings per share (Unadj.) Rs-79.248.7 -162.7%  
Cash flow per share (Unadj.) Rs-43.575.8 -57.3%  
Dividends per share (Unadj.) Rs015.00 0.0%  
Dividend yield (eoy) %00.7 0.0%  
Book value per share (Unadj.) Rs53.9462.9 11.7%  
Shares outstanding (eoy) m70.4545.75 154.0%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.44.9 8.4%   
Avg P/E ratio x-1.444.5 -3.2%  
P/CF ratio (eoy) x-2.628.6 -9.2%  
Price / Book Value ratio x2.14.7 45.3%  
Dividend payout %030.8 0.0%   
Avg Mkt Cap Rs m8,06799,163 8.1%   
No. of employees `0002.82.9 96.9%   
Total wages/salary Rs m2,5272,758 91.6%   
Avg. sales/employee Rs Th6,956.16,981.7 99.6%   
Avg. wages/employee Rs Th902.5954.5 94.6%   
Avg. net profit/employee Rs Th-1,993.0771.1 -258.5%   
INCOME DATA
Net Sales Rs m19,47720,170 96.6%  
Other income Rs m407857 47.5%   
Total revenues Rs m19,88421,028 94.6%   
Gross profit Rs m1,1034,310 25.6%  
Depreciation Rs m2,5191,239 203.4%   
Interest Rs m5,2275 100,515.4%   
Profit before tax Rs m-6,2363,923 -159.0%   
Minority Interest Rs m200-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m51199 516.8%   
Tax Rs m-1251,794 -7.0%   
Profit after tax Rs m-5,5802,228 -250.5%  
Gross profit margin %5.721.4 26.5%  
Effective tax rate %2.045.7 4.4%   
Net profit margin %-28.711.0 -259.4%  
BALANCE SHEET DATA
Current assets Rs m11,01416,299 67.6%   
Current liabilities Rs m32,0607,594 422.2%   
Net working cap to sales %-108.143.2 -250.4%  
Current ratio x0.32.1 16.0%  
Inventory Days Days9565 145.4%  
Debtors Days Days3426 130.3%  
Net fixed assets Rs m29,4408,622 341.5%   
Share capital Rs m705458 154.0%   
"Free" reserves Rs m2,04320,722 9.9%   
Net worth Rs m3,80021,180 17.9%   
Long term debt Rs m9,01825 36,071.6%   
Total assets Rs m46,51029,137 159.6%  
Interest coverage x-0.2755.5 -0.0%   
Debt to equity ratio x2.40 201,056.0%  
Sales to assets ratio x0.40.7 60.5%   
Return on assets %-0.87.7 -9.9%  
Return on equity %-146.910.5 -1,396.2%  
Return on capital %-3.719.0 -19.7%  
Exports to sales %37.90.1 63,668.0%   
Imports to sales %22.617.5 129.4%   
Exports (fob) Rs m7,37812 61,480.0%   
Imports (cif) Rs m4,4063,526 125.0%   
Fx inflow Rs m7,51352 14,546.6%   
Fx outflow Rs m5,649140 4,035.4%   
Net fx Rs m1,865-88 -2,110.8%   
CASH FLOW
From Operations Rs m1,6823,436 48.9%  
From Investments Rs m-9,860-6,991 141.0%  
From Financial Activity Rs m6,644-619 -1,073.7%  
Net Cashflow Rs m-1,535-4,174 36.8%  

Share Holding

Indian Promoters % 32.3 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 4.6 7.5 61.3%  
FIIs % 3.3 4.9 67.3%  
ADR/GDR % 4.6 0.0 -  
Free float % 55.3 23.7 233.3%  
Shareholders   84,811 85,207 99.5%  
Pledged promoter(s) holding % 54.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA LTD With:   BIOCON LTD  CADILA HEALTHCARE  SUVEN LIFE  PLETHICO PHARMA  GLENMARK PHARMA  

Compare ORCHID PHARMA LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Extends Losses; Pharma Stocks Top Losers(Closing)

After opening the day in red share markets in India witnessed negative trading activity throughout the day, and ended well below the dotted line.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Looking Beyond the Colourful Prism of This Airline Company(Sector Info)

May 10, 2018

Can Interglobe Aviation Safely Fly Out of Turbulence?

HDFC Prudence Fund Now HDFC Balanced Advantage Fund - Time To Sell?(Outside View)

May 9, 2018

PersonalFN provides detail analysis on HDFC Balanced Advantage Fund (erstwhile HDFC Prudence Fund and HDFC Growth Fund).

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


May 21, 2018 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD - PLETHICO PHARMA COMPARISON

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS